Jane Street »

Theriva Biologics shares owned by Jane Street

Quarter-by-quarter ownership of Theriva Biologics (TOVX) shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Theriva Biologics

Tip: Access up to 7 years of quarterly data

All positions including Theriva Biologics held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theriva Biologics by Jane Street

Quarter filed Position value Share count Share price at filing
2025-09-30 $15k 37k 0.41

More positions owned by Jane Street

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Spdr Gold Tr Gold Shs (GLD)
Apple Call Option (AAPL)
Taiwan Semiconductor Mfg Sponsored Ads Put Option (TSM)
Microsoft Corporation Call Option (MSFT)
Advanced Micro Devices Call Option (AMD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Strategy Cl A New (MSTR)
Broadcom Call Option (AVGO)
Amazon Call Option (AMZN)

View all positions for Jane Street

Top funds holding Theriva Biologics

Ikarian Capital
Two Sigma Investments
Virtu Financial
Jane Street
Boothbay Fund Management
XTX Topco
Geode Capital Management
Two Sigma Advisers
UBS Group
Vanguard Group
Hrt Financial
BlackRock
Advisor Group Holdings
Clear Street
SBI Securities

View all funds holding Theriva Biologics